Notably, owing to the large number of diabetic patients using DPP-4 inhibitors worldwide, a great number of cases of acute pancreatitis might be prevented by taking into account pre-existing risk factors for acute pancreatitis, such as gallstones and hypertriglyceridaemia, when considering whether to prescribe this type of medication. The gene discussed is DPP4; the disease is gallstones.